首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Ejhaem

缩写:

ISSN:2688-6146

e-ISSN:2688-6146

IF/分区:1.3/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引1401条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Jad Sibai,RuiQi Chen,Ibrahim Al Nabhani et al. Jad Sibai et al.
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy. It is associated with poor prognosis and heterogenous presentation. The CD123-directed cytotoxin, Tagraxofusp, is a targeted therapy for B...
Mathieu Meunier,Sophie Park Mathieu Meunier
Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematological disorders. Treatment options are classified and defined by prognostic risk based on the International Prognostic Scoring System (IPSS) and, more recently, the...
Heidi M Heyman,Nicole M Alberts,Matthew Rees et al. Heidi M Heyman et al.
Adolescents with sickle cell disease (SCD) have been shown to have pain-related sequelae following COVID-19 infection. In this case series, we discuss five adolescents with SCD and SARS-CoV-2 infection who subsequently developed complex pai...
Naveen Pemmaraju,Claire Harrison,Vikas Gupta et al. Naveen Pemmaraju et al.
The safety profile of the novel oral JAK2/IRAK1 inhibitor pacritinib in patients with cytopenic myelofibrosis was described in the Phase 2 PAC203 and Phase 3 PERSIST-2 studies. To account for longer treatment durations on the pacritinib arm...
Jie Luo,Xin Du,Jin Lou et al. Jie Luo et al.
Background: Long-term treatment-free remission (TFR) represents a new goal for chronic myeloid leukemia (CML). Optimizing dose of tyrosine kinase inhibitors (TKIs) in the CML treatment maybe a new challenge to maintain effective and improvi...
Abhinav Mathur,Joakim Edman,Livia Liang et al. Abhinav Mathur et al.
Hydroxycarbamide (HC) is used as a cytoreductive treatment in myeloproliferative neoplasms (MPN). Observational studies have raised the possibility that HC contributes to the development of secondary malignancies, including skin tumours in ...
Firas Safa,Terri Rasmussen,Patricia Lobelle-Rich et al. Firas Safa et al.
Cell lines represent an essential tool used in preclinical research. Most hematologic malignancies have a wide array of cell lines representing their respective molecular and pathologic spectra. In mantle cell lymphoma (MCL), cell lines bec...